NCT03097627 is a Phase 1, PHASE2 clinical trial of ICG Intervention in Pulmonary Nodule, Solitary, sponsored by Brigham and Women's Hospital.

Who is sponsoring NCT03097627?

NCT03097627 is sponsored by Brigham and Women's Hospital.

What drugs are being tested in NCT03097627?

Interventions in NCT03097627: ICG Intervention, Near Infrared Camera.

What condition does NCT03097627 study?

NCT03097627 studies Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple.

Is NCT03097627 still recruiting?

NCT03097627 is currently completed. Last updated 12 December 2017.

Last reviewed 2017-12-12 · How we verify

NCT03097627

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions

Completed Phase 1, PHASE2 Last updated 12 December 2017

What this trial tests

Phase 1, PHASE2 trial testing ICG Intervention in Pulmonary Nodule, Solitary in 4 participants. Completed in 28 October 2016.

Timeline

1 February 2016

Primary endpoint
28 October 2016

28 October 2016

Quick facts

Lead sponsor	Brigham and Women's Hospital
Phase	Phase 1, PHASE2
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	4
Start date	1 February 2016
Primary completion	28 October 2016
Estimated completion	28 October 2016
Sites	1 location across United States

Drugs / interventions tested

ICG Intervention — full drug profile →
Near Infrared Camera

Conditions studied

Pulmonary Nodule, Solitary — all drugs for Pulmonary Nodule, Solitary →
Pulmonary Nodule, Multiple — all drugs for Pulmonary Nodule, Multiple →

Sponsor

Brigham and Women's Hospital

Who can join

18 and older, any sex, with Pulmonary Nodule, Solitary or Pulmonary Nodule, Multiple. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ICG Intervention

Trials testing the same drug.

NCT03097575 — Bronchial NIR Image-guided Resection · Phase 1, PHASE2 · recruiting

Other recruiting trials for Pulmonary Nodule, Solitary

Currently open trials in the same condition.

NCT07322796 — Smoking Cessation Before Bronchoscopy or CT-guided Puncture · recruiting
NCT06308120 — A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis · NA · active not recruiting
NCT05968898 — Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES · NA · recruiting
NCT07537556 — Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost- · active not recruiting
NCT06426628 — Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier · recruiting

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03097627 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
Last refreshed: 12 December 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03097627.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing